시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 In Vivo 수탁 연구기관 시장 보고서(2025년)
In Vivo Contract Research Organization Global Market Report 2025
상품코드 : 1810918
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,294,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,098,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,902,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

In Vivo 수탁 연구기관 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 연평균 성장률(CAGR) 8.3%로 71억 9,000만 달러로 성장합니다. 예측 기간 중 예상되는 성장은 정밀의료에 대한 수요 증가, 의약품 개발 수탁기관의 세계 서비스 네트워크 확대, 개인 맞춤형 치료제의 출현, 중개연구에 대한 수요 증가, 희귀질환 치료제 증가에 기인합니다. 이 기간 중 예상되는 주요 동향으로는 in vivo 모델용 첨단 이미징 기술, 데이터 처리 및 보고 자동화, 오믹스 기술 통합, 클라우드 기반 공동 연구 플랫폼, 생물제제 바이오시밀러 개발 등이 있습니다.

맞춤형 의료가 강조되면서 In Vivo 위탁연구기관 시장의 향후 성장이 기대됩니다. 맞춤형 의료는 개인의 유전적 프로파일, 생활습관, 환경에 따라 치료 및 예방 전략을 맞춤화하여 건강 결과를 향상시키는 것입니다. 이러한 관심 증가는 유전자 변이를 보다 정확하게 식별할 수 있는 유전체 염기서열 분석 기술에 대한 접근성이 향상되고 가격이 저렴해진 것이 주요 요인으로 작용했습니다. 그 결과, 환자의 결과를 개선하고 치료의 시행착오를 최소화하는 맞춤형 치료법이 개발됩니다. 맞춤형 의료에 대한 관심이 높아지면서 in vivo CRO 시장 수요가 증가하고 있습니다. 표적 치료제와 그 고유한 유전자 프로파일에 미치는 영향을 평가하기 위해서는 특정 동물 모델을 이용한 맞춤형 전임상시험이 필요하기 때문입니다. 예를 들어 미국 비영리단체인 Personalized Medicine Coalition(PMC)에 따르면 FDA는 2022년에 6개의 새로운 개인화 치료제를 승인한 반면, 2023년에는 16개의 새로운 개인화 치료제를 승인했습니다. FDA의 신약 승인 중 개인맞춤형 치료제가 차지하는 비중은 4년 연속으로 1/3을 넘어섰습니다. 이처럼 맞춤형 의료에 대한 관심이 높아지면서 In Vivo 위탁연구기관 시장의 성장을 촉진하고 있습니다.

In Vivo 위탁연구기관 시장의 주요 업체들은 차세대 치료제 개발을 가속화하고 초기 임상연구를 지원하는 첨단 치료 인큐베이터 프로그램과 같은 혁신적인 구상에 집중하고 있습니다. 이 인큐베이터 프로그램은 유전자, 세포, RNA 기반 치료제 등 초기 단계의 생명공학 기업을 지원하기 위해 전문 리소스, 멘토링, 인프라를 제공합니다. 예를 들어 2025년 4월 미국 제약회사 찰스 리버 래버러 연구소 인터내셔널(Charles River Laboratories International Inc.)은 첫 번째 첨단 치료 인큐베이터 프로그램 코호트를 출범시켰습니다. 이 프로그램은 찰스 리버의 과학적 전문성, 최첨단 연구시설, 맞춤형 생체내 모델에 대한 접근성을 제공함으로써 차세대 치료법을 개발하는 초기 단계의 생명공학 기업을 지원하는 것을 목표로 합니다. 참여 기업은 실제와 유사한 전임상시험 환경에서 신속하게 개념증명 데이터를 생성하고, 치료제 후보물질을 검증할 수 있으며, 임상시험까지의 기간을 단축하고 허가 가능성을 높일 수 있습니다. 이 구상은 학술적 혁신과 임상 개발의 격차를 해소함으로써 첨단 치료법의 발전에 중요한 역할을 하고 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSA
영문 목차

영문목차

In vivo contract research organizations are specialized service providers that perform research and testing using live animals to assess the safety, efficacy, and pharmacological impacts of drug candidates or medical devices prior to human clinical trials. These organizations are essential in preclinical development, offering services such as toxicology, pharmacokinetics, and disease modeling with both rodent and non-rodent models.

The primary types of in vivo contract research organizations are rodent-based and non-rodent-based. Rodent-based research involves preclinical testing using rodents like mice or rats as model organisms to evaluate the safety, efficacy, and biological effects of new drugs or treatments before they reach human trials. Services typically include clinical trial support, preclinical testing, and post-market evaluations. These organizations follow various laboratory standards, including good laboratory practice (GLP) toxicology and non-GLP protocols. Their research spans numerous therapeutic areas such as oncology, cardiovascular diseases, infectious diseases, neurological disorders, and more. They serve a diverse group of end users, including pharmaceutical and biotechnology companies, contract research organizations (CROs), academic and research institutions, as well as government and regulatory agencies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The in vivo contract research organization market research report is one of a series of new reports from The Business Research Company that provides in vivo contract research organization market statistics, including in vivo contract research organization global market size, regional shares, competitors with in vivo contract research organization market share, detailed in vivo contract research organization market segments, market trends and opportunities, and any further data you may need to thrive in the in vivo contract research organization industry. The in vivo contract research organization market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The in vivo contract research organization market size has grown strongly in recent years. It will grow from $4.82 billion in 2024 to $5.23 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth during the historic period can be attributed to escalating drug development costs, a rising prevalence of chronic diseases, increased investment in pharmaceutical research and development, the expansion of biotechnology startups, and strong demand for innovative therapeutics.

The in vivo contract research organization market size is expected to see strong growth in the next few years. It will grow to $7.19 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth projected for the forecast period can be attributed to rising demand for precision medicine, the global expansion of contract research organization service networks, the emergence of personalized therapeutics, an increasing need for translational research, and the growing number of orphan drugs. Key trends expected during this period include advanced imaging techniques for in vivo models, automation in data processing and reporting, the integration of omics technologies, cloud-based collaboration platforms, and developments in biologics biosimilars.

The increasing emphasis on personalized medicine is expected to drive growth in the in vivo contract research organization market moving forward. Personalized medicine customizes treatment and prevention strategies based on an individual's genetic profile, lifestyle, and environment to enhance health outcomes. This growing focus is largely due to the improved accessibility and affordability of genomic sequencing technologies, which allow for more precise identification of genetic mutations. As a result, tailored therapies can be developed that improve patient outcomes and minimize trial-and-error in treatment. The rising attention to personalized medicine fuels demand in the in vivo CRO market because customized preclinical studies using specific animal models are required to assess targeted therapies and their effects on unique genetic profiles. For example, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the FDA approved 16 new personalized treatments in 2023, compared to six in 2022. Personalized medicines have accounted for more than one-third of all new drug approvals by the FDA for the fourth consecutive year. Thus, the growing focus on personalized medicine is propelling the growth of the in vivo contract research organization market.

Key players in the in vivo contract research organization market are concentrating on innovative initiatives such as advanced therapy incubator programs to accelerate the development of next-generation therapeutics and support early-stage clinical research. These incubator programs provide specialized resources, mentorship, and infrastructure to assist early-stage biotechnology companies in advancing therapies such as gene, cell, and RNA-based treatments. For instance, in April 2025, Charles River Laboratories International Inc., a US-based pharmaceutical company, launched its first advanced therapy incubator program cohort. This program is designed to support early-stage biotech firms developing next-generation therapies by offering access to Charles River's scientific expertise, cutting-edge laboratory facilities, and customized in vivo models. Participants can quickly generate proof-of-concept data and validate therapeutic candidates in a real-world preclinical setting, helping to shorten time-to-clinic and increase the likelihood of regulatory approval. By bridging the gap between academic innovation and clinical development, this initiative plays a vital role in advancing advanced therapies.

In September 2024, PharmaLegacy Laboratories Co. Ltd., a China-based preclinical contract research organization specializing in pharmacology, acquired BTS Research for an undisclosed amount. This acquisition aims to enhance PharmaLegacy's preclinical service capabilities and establish a strategic laboratory presence in North America to better support global biopharmaceutical clients. BTS Research Inc. is a US-based biotech company offering both in vitro and in vivo research programs.

Major players in the in vivo contract research organization market are Thermo Fisher Scientific Inc., IQVIA Inc., Labcorp Drug Development Inc., ICON plc, Pharmaceutical Product Development LLC, Eurofins Scientific SE, WuXi AppTec, Syneos Health Inc., Charles River Laboratories International Inc., Parexel International Corporation, Evotec SE, GemPharmatech Co Ltd., BIOQUAL Inc., Crown Bioscience Inc., PsychoGenics Inc., Janvier Labs SAS, Taconic Bioscience Inc., Xentech SAS, Pronexus Analytical AB, Altogen Labs Inc., and AniLocus Inc.

North America was the largest region in the in vivo contract research organization market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in in vivo contract research organization report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the in vivo contract research organization market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The in vivo contract research organization market includes revenues earned by entities by providing services such as conducting pharmacokinetic studies, toxicology testing, and efficacy studies, and related services such as animal modeling, biomarker analysis, and data interpretation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In Vivo Contract Research Organization Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in vivo contract research organization market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for in vivo contract research organization ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The in vivo contract research organization market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. In Vivo Contract Research Organization Market Characteristics

3. In Vivo Contract Research Organization Market Trends And Strategies

4. In Vivo Contract Research Organization Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global In Vivo Contract Research Organization Growth Analysis And Strategic Analysis Framework

6. In Vivo Contract Research Organization Market Segmentation

7. In Vivo Contract Research Organization Market Regional And Country Analysis

8. Asia-Pacific In Vivo Contract Research Organization Market

9. China In Vivo Contract Research Organization Market

10. India In Vivo Contract Research Organization Market

11. Japan In Vivo Contract Research Organization Market

12. Australia In Vivo Contract Research Organization Market

13. Indonesia In Vivo Contract Research Organization Market

14. South Korea In Vivo Contract Research Organization Market

15. Western Europe In Vivo Contract Research Organization Market

16. UK In Vivo Contract Research Organization Market

17. Germany In Vivo Contract Research Organization Market

18. France In Vivo Contract Research Organization Market

19. Italy In Vivo Contract Research Organization Market

20. Spain In Vivo Contract Research Organization Market

21. Eastern Europe In Vivo Contract Research Organization Market

22. Russia In Vivo Contract Research Organization Market

23. North America In Vivo Contract Research Organization Market

24. USA In Vivo Contract Research Organization Market

25. Canada In Vivo Contract Research Organization Market

26. South America In Vivo Contract Research Organization Market

27. Brazil In Vivo Contract Research Organization Market

28. Middle East In Vivo Contract Research Organization Market

29. Africa In Vivo Contract Research Organization Market

30. In Vivo Contract Research Organization Market Competitive Landscape And Company Profiles

31. In Vivo Contract Research Organization Market Other Major And Innovative Companies

32. Global In Vivo Contract Research Organization Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The In Vivo Contract Research Organization Market

34. Recent Developments In The In Vivo Contract Research Organization Market

35. In Vivo Contract Research Organization Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기